GWP
TMDX icon

Gen-Wealth Partners’s Transmedics TMDX Stock Holding History

Gen-Wealth Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-545
Closed -$82.1K – 717
2024
Q2 		$82.1K Buy
+545
New +$65.4K 0.04% 310

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Gen-Wealth Partners's TMDX Position: Q3 2024 in Review

Gen-Wealth Partners sold out of Transmedics (TMDX) in Q3 2024, closing a stake of 545 shares — an estimated $82.1K sold.

Gen-Wealth Partners first reported a position in TMDX in Q2 2024 and held it in 1 quarter. The position peaked at $82.1K in Q2 2024. 373 funds tracked by Wall St. Rank hold TMDX as of Q3 2024.

  • Gen-Wealth Partners reported no remaining Transmedics position as of Q3 2024 after selling out during the quarter.
  • Gen-Wealth Partners sold 545 Transmedics shares in Q3 2024, an estimated $82.1K.
  • Gen-Wealth Partners first reported a position in Transmedics in Q2 2024 and held it in 1 quarter.
  • Gen-Wealth Partners's Transmedics position peaked at $82.1K in Q2 2024.
  • 373 funds tracked by Wall St. Rank held Transmedics as of Q3 2024.

Based on Gen-Wealth Partners's 13F filing for Q3 2024, filed 13 Nov 2024.